HCA Healthcare Inc's stock plummeted 5.02% during intraday trading on Wednesday, following the release of its fourth-quarter 2025 financial results.
The hospital chain operator reported mixed quarterly performance, with total revenues of $19.513 billion representing a 6.7% year-over-year increase but missing the consensus estimate of $19.67 billion. While adjusted earnings of $8.01 per share surpassed both the year-ago figure of $6.22 and the consensus estimate of $7.43, the revenue shortfall appears to have concerned investors.
Additionally, the company's fiscal 2026 guidance may have contributed to the negative market reaction. HCA Healthcare forecasts 2026 sales in the range of $76.5 billion to $80 billion, compared to the consensus estimate of $79.08 billion, with the lower end of the guidance falling below analyst expectations.
Comments